# How Many Dexamethasone Doses Should Be Given Perioperatively?

> **NCT06715709** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 339 (estimated)

## Conditions studied

- Arthropathy of Knee

## Interventions

- **DRUG:** Dexamethasone IV
- **DRUG:** Dexamethasone IV+Oral
- **DRUG:** Dexamethasone IV+Oral 2 Day

## Key facts

- **NCT ID:** NCT06715709
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-03-25
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 339 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715709, "How Many Dexamethasone Doses Should Be Given Perioperatively?". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06715709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*